Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 1144820210270020095
´ëÇÑÀÇ»ý¸í°úÇÐȸÁö
2021 Volume.27 No. 2 p.95 ~ p.98
Pro-apoptotic Effects of S100A8 and S100A9 on human FIP1L1-PDGFR¥á+ Eosinophilic Leukemia Cells
Lee Ji-Sook

Abstract
The S100 family proteins act as inducers of cancer cell apoptosis and inflammatory mediators. This study examined the pro-apoptotic mechanism caused by S100A8 and S100A9 in human FIP1L1-PDGFR¥á-positive eosinophilic leukemia cells. S100A8 and S100A9 elicited the death of EoL-1 cells in a time and dose-dependent manner. The activation of PDGFR¥á was suppressed by a decrease in PDGFR¥á after treatment with S100A8 and S100A9. Cycloheximide, a translation inhibitor, suppressed PDGFR¥á expression from 1 h to 5 h, and a co-treatment with S100A8 and S100A9 boosted the decrease in expression. The phosphorylation and expression of STAT5 decreased after treatment with S100A8 and S100A9 in EoL-1 and imatinib-resistant (EoL-1-IR) cells. S100A8 and S100A9 induced the chemotaxis of EoL-1 cells but did not affect the chemoattraction of EoL-1-IR. These findings indicate the cell death mechanism due to S100 family proteins and the development of leukemia therapy using S100A8 and S100A9.
KEYWORD
S100, FIP1L1-PDGFR¥á, Chronic eosinophil leukemia
FullTexts / Linksout information
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI)